Patient-friendly peptide education
General peptide therapy, clinics, safety, brands and long-tail topics.
Recently published
Fertility Peptides 2026 Update — Latest Research & Protocols Fewer than 15% of reproductive endocrinology clinics in 2026 incorporate research-grade peptides into standard fertility protocols. Yet kisspeptin a…
Read guide →How to Use Peptides for Fertility — Protocol Essentials Research from the Endocrine Society's 2024 symposium identified growth hormone secretagogues and thymic peptides as the two most frequently investigated …
Read guide →Psoriasis Peptides 2026 Update — Latest Research & Mechanisms Clinical trials published in JAMA Dermatology in early 2026 found that synthetic peptides targeting IL-17A demonstrated 68% PASI-75 response at 12 …
Read guide →Peptides for Psoriasis — Research-Grade Options A 2023 study published in the Journal of Investigative Dermatology found that KPV, a tripeptide derived from alpha-MSH, reduced IL-17 expression in keratinocytes…
Read guide →Peptides for Fertility — Research Applications & Protocols A 2024 systematic review published in Reproductive Biology and Endocrinology analyzed 47 preclinical studies investigating peptide-based interventions…
Read guide →Do Peptides Help with Psoriasis? (Clinical Evidence) Research from Oregon Health & Science University found that the cytokine IL-17A, a primary driver of psoriatic plaque formation, can be modulated by specifi…
Read guide →How to Use Peptides for Psoriasis — Treatment Protocol Research published in the Journal of Investigative Dermatology found that peptides targeting the IL-17/IL-23 axis reduced keratinocyte proliferation marke…
Read guide →Best Peptides for Psoriasis — What Works (2026 Research) Research published in the Journal of Investigative Dermatology found that dysregulated T-cell activation drives psoriatic plaque formation through IL-17…
Read guide →Eczema Peptides 2026 Update — Clinical Breakthroughs A Phase 2 trial published in January 2026 demonstrated that synthetic thymosin beta-4 fragments reduced eczema flare frequency by 58% over 16 weeks compared…
Read guide →Peptides for Eczema — Research Insights & Clinical Context Research from Duke University published in The Journal of Investigative Dermatology found that antimicrobial peptides (AMPs) like LL-37 are significan…
Read guide →Do Peptides Help with Eczema? Science-Backed Evidence Clinical data from a 2024 randomised controlled trial published in the Journal of the American Academy of Dermatology found that topical application of bar…
Read guide →Best Peptides for Eczema — Clinical Evidence & Application Research from multiple institutions including Johns Hopkins and the National Institutes of Health has identified three peptide compounds. KPV (alpha-m…
Read guide →How to Use Peptides for Eczema — Research & Application Atopic dermatitis affects roughly 31 million people across North America, yet fewer than 15% of patients achieve sustained remission using conventional s…
Read guide →Do Peptides Help With Cancer Research? (2026 Data) A 2023 study published in Nature Reviews Drug Discovery found that peptide-based therapeutics now represent 15% of all oncology drugs in clinical trials. A 24…
Read guide →Peptides for Cancer Research — Precision Tools Researchers at Johns Hopkins in 2024 published a study demonstrating that a single 15-amino-acid synthetic peptide targeting PD-1 receptors outperformed full-leng…
Read guide →Cancer Research Peptides 2026 Update — What's Changed Phase II trial data released in early 2026 shows ADC (antibody-drug conjugate) peptide linkers achieving tumor-specific payload delivery rates above 85%. N…
Read guide →Best Peptides for Cancer Research — Mechanisms & Applications Most cancer research peptides don't work through cytotoxic mechanisms. They modulate immune checkpoints, disrupt angiogenesis signaling, or activat…
Read guide →How to Use Peptides for Cancer Research — Precise Protocol Research into peptide-based cancer therapeutics has accelerated dramatically since 2020, with over 140 peptide candidates currently in clinical trials…
Read guide →Osteoporosis Peptides 2026 Update — What Changed Research published in JAMA Internal Medicine in January 2026 found that PTH 1-34 analogs paired with sclerostin inhibitors reduced fracture risk by 61% compared…
Read guide →How to Use Peptides for Osteoporosis — Research Protocols Nearly 54 million adults in the U.S. have low bone density, yet fewer than 30% achieve meaningful improvement with standard bisphosphonate therapy. Not…
Read guide →Browse by subject
Each topic opens a crawlable collection of related articles and resources.